PPD names Dr Christine Dingivan executive VP and chief medical officer
This article was originally published in Scrip
Executive Summary
PPD (US) has appointed Dr Christine Dingivan executive vice-president and chief medical officer. Before joining the company, Dr Dingivan spent 12 years at MedImmune, a biologics business acquired by AstraZeneca in 2007, most recently serving as senior vice-president of clinical development and operations.